Condition
Type 1 Interferonopathies clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Type 1 Interferonopathies clinical trials that are recruiting, at sites in 2 countries (most in Australia (1), Italy (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1New in 30 days
- 2Countries
All recruiting trials (2)
-
Gene editing and iPS cells to study and treat monogenic autoinflammatory diseases
Researchers are testing whether correcting disease-causing mutations in patient-derived cells can help treat autoinflammatory conditions like SAVI and COPA using gene editing and iPSC technology.
-
Phase 1b safety test of IMSB301 for people with Type 1 interferonopathies
This trial tests whether IMSB301 is safe and well tolerated when given alone to people with genetically confirmed Type 1 interferonopathies.
Related topics
Quick answers
How many Type 1 Interferonopathies clinical trials are recruiting right now?
2, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (1 trial), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.